Nektar Therapeutics | NKTR - Current Assets


Nektar Therapeutics reported $266.27M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Agios Pharmaceuticals USD 834.84M 107.21M Mar/2026
ALKERMES USD 1.36B 570.52M Mar/2026
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Amgen USD 31.48B 2.42B Mar/2026
Baxter International USD 6.85B 25M Mar/2026
BioCryst Pharmaceuticals USD 404.35M 48.66M Dec/2025
Biogen USD 9.19B 216.3M Mar/2026
Bristol-Myers Squibb USD 27.21B 2.18B Mar/2026
Cara Therapeutics USD 38.44M 4.69M Sep/2025
Cipla INR 249.18B 16.3B Sep/2025
Dr.Reddys Laboratories INR 297.55B 18.03B Dec/2025
Eisai JPY 840.88B 50.18B Dec/2025
Eli Lilly USD 54.84B 794M Mar/2026
Esperion Therapeutics USD 462.57M 102.11M Dec/2025
Exelixis USD 1.44B 41.03M Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
GlaxoSmithKline GBP 17.76B 251M Mar/2026
Grifols EUR 5.96B 316.31M Dec/2025
Halozyme Therapeutics USD 825.21M 503.54M Dec/2025
Incyte USD 5.48B 460.36M Mar/2026
Ionis Pharmaceuticals USD 2.94B 52M Mar/2026
Ironwood Pharmaceuticals USD 273.84M 82.09M Sep/2025
Karyopharm Therapeutics USD 103.15M 13.4M Dec/2025
MacroGenics USD 219.94M 12.15M Dec/2025
Merck USD 35.02B 8.5B Mar/2026
Nektar Therapeutics USD 266.27M 15.09M Dec/2025
Neurocrine Biosciences USD 2.44B 86.6M Mar/2026
Novartis USD 26.61B 3.85B Mar/2026
Pfizer USD 42.82B 76M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Sarepta Therapeutics USD 2.54B 184.37M Dec/2025
Takeda JPY 3.12T 195.82B Dec/2025
Teva Pharmaceutical Industries USD 13.71B 236M Mar/2026
Xencor USD 599.82M 81.38M Dec/2025